Contact us

Contact us

Contact us

Wether you are a visionary academic seeking collaboration, an investor searching to make meaningful impact or an owner of a companion animal with cancer, we are here to facilitate connections that drive the future of healthcare in companion animals

* The information provided through this contact form is for inquiry purposes only and does not constitute veterinary advice or establish any professional relationship. For veterinary emergencies, please contact your local emergency veterinary clinic immediately. All clinical treatments are experimental and subject to regulatory approval and eligibility criteria. Investment-related communications do not constitute solicitation.

Alvb.no Office Headquarters in Norway
Alvb.no Office Headquarters in Norway
Alvb.no Office Headquarters in Norway

Contact details

Address

Pløens gate 7, Oslo

Hours of Operation

Monday to Friday 09-17

Alv B AS is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.

Alv B AS Copyright 2025 © All Right Reserved.

Alv B AS is a registered company in Norway (Org.nr. 924 846 208). The company is authorized under the Norwegian Medicines Agency and operates in compliance with the Norwegian Animal Welfare Act. Alv B AS is authorized by the Norwegian Food Safety Authority (Mattilsynet) for conducting clinical trials in veterinary medicine (Approval No. MT-2023-0845). All research and development activities are conducted in accordance with Norwegian biotechnology regulations and international standards for comparative oncology research.

Alv B AS is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.

Alv B AS Copyright 2025 © All Right Reserved.

Alv B AS is a registered company in Norway (Org.nr. 924 846 208). The company is authorized under the Norwegian Medicines Agency and operates in compliance with the Norwegian Animal Welfare Act. Alv B AS is authorized by the Norwegian Food Safety Authority (Mattilsynet) for conducting clinical trials in veterinary medicine (Approval No. MT-2023-0845). All research and development activities are conducted in accordance with Norwegian biotechnology regulations and international standards for comparative oncology research.

Alv B AS is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.

Alv B AS Copyright 2025 © All Right Reserved.

Alv B AS is a registered company in Norway (Org.nr. 924 846 208). The company is authorized under the Norwegian Medicines Agency and operates in compliance with the Norwegian Animal Welfare Act. Alv B AS is authorized by the Norwegian Food Safety Authority (Mattilsynet) for conducting clinical trials in veterinary medicine (Approval No. MT-2023-0845). All research and development activities are conducted in accordance with Norwegian biotechnology regulations and international standards for comparative oncology research.